| ||
FDA raises safety concerns for Vivus diet pill Seattle Post Intelligencer WASHINGTON (AP) — Federal health officials continue to voice safety concerns about an experimental diet pill from drugmaker Vivus Inc., as the company prepares to make a second attempt to convince experts of the drugs' safety next week. See all stories on this topic » |
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment